 | Global Blood Therapeutics (NASDAQ:GBT) Cut to Market Perform at William Blair
marketbeat.com - February 25 at 8:46 AM |
 | Q1 2021 Earnings Estimate for Global Blood Therapeutics, Inc. (NASDAQ:GBT) Issued By William Blair
americanbankingnews.com - March 1 at 2:28 AM |
| Research Analysts Set Expectations for Global Blood Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:GBT)
americanbankingnews.com - March 1 at 2:28 AM |
| Truist Securiti Comments on Global Blood Therapeutics, Inc.'s Q1 2021 Earnings (NASDAQ:GBT)
americanbankingnews.com - March 1 at 1:56 AM |
 | Global Blood (GBT) Q4 Earnings Miss, Revenues Beat Estimates
nasdaq.com - February 25 at 3:56 PM |
| Global Blood Therapeutics (NASDAQ:GBT) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS
americanbankingnews.com - February 25 at 2:04 PM |
| William Blair Lowers Global Blood Therapeutics (NASDAQ:GBT) to Market Perform
americanbankingnews.com - February 25 at 9:37 AM |
 | Recap: Global Blood Therapeutics Q4 Earnings
finance.yahoo.com - February 25 at 12:11 AM |
| GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 24 at 7:11 PM |
| Preview: Global Blood Therapeutics's Earnings
finance.yahoo.com - February 23 at 2:21 PM |
|
| Global Blood Therapeutics (GBT) Set to Announce Earnings on Wednesday
americanbankingnews.com - February 18 at 9:27 AM |
| GBT to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
finance.yahoo.com - February 17 at 12:00 PM |
| Is Global Blood Therapeutics (NASDAQ:GBT) A Risky Investment?
finance.yahoo.com - February 8 at 9:08 AM |
 | GBT Initiates Expanded Access Protocol for Oxbryta(R) (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
marketwatch.com - February 5 at 9:57 AM |
| GBT Initiates Expanded Access Protocol for Oxbryta® (voxelotor) in Pediatric Patients with Sickle Cell Disease in the United States
finance.yahoo.com - February 4 at 1:08 PM |
 | Global Blood Therapeutics, Inc.: European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for
bloomberg.com - January 28 at 7:45 PM |
| European Medicines Agency Accepts GBT’s Marketing Authorization Application (MAA) for Oxbryta® (voxelotor) for the Treatment of Hemolytic Anemia in Sickle Cell Disease
finance.yahoo.com - January 27 at 7:25 AM |
| GBT Announces Participation at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 8:43 AM |
| Loss-Making Global Blood Therapeutics, Inc. (NASDAQ:GBT) Expected To Breakeven In The Medium-Term
finance.yahoo.com - December 25 at 12:25 PM |
 | Global Blood Therapeutics: More Growth For Inclacumab
seekingalpha.com - December 14 at 3:38 PM |
 | Global Blood Therapeutics Inc.
barrons.com - December 10 at 12:02 AM |
| GBT Appoints Kim Smith-Whitley, M.D., to Lead Research and Development
finance.yahoo.com - December 7 at 8:32 AM |
| GBT Presents New Data on the Long-Term and Real-World Use of Oxbryta® (voxelotor) Tablets in Patients with Sickle Cell Disease at 62nd ASH Annual Meeting and Exposition
finance.yahoo.com - December 6 at 4:39 PM |
| Why Is Global Blood (GBT) Down 27.3% Since Last Earnings Report?
finance.yahoo.com - December 5 at 5:48 PM |
| GBT Initiates Early Access Program for Voxelotor in Patients with Sickle Cell Disease in Europe and Other Regions Outside the United States
finance.yahoo.com - December 2 at 7:46 AM |
| Global Blood Therapeutics: 40% Discount On A Billion-Dollar Drug
seekingalpha.com - November 19 at 10:18 PM |
| Global Blood Therapeutics (GBT) Surges: Stock Moves 6.9% Higher
finance.yahoo.com - November 13 at 1:18 PM |
| GBT Announces Participation at the Stifel 2020 Virtual Healthcare Conference
finance.yahoo.com - November 13 at 8:18 AM |
|
| Analysts Just Slashed Their Global Blood Therapeutics, Inc. (NASDAQ:GBT) EPS Numbers
finance.yahoo.com - November 10 at 8:14 AM |
| Global Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 4:12 PM |
| Global Blood Therapeutics, Inc. (NASDAQ:GBT) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 12:30 PM |
| Global Blood Therapeutics is Now Oversold (GBT)
nasdaq.com - November 6 at 8:11 PM |
 | Mid-Afternoon Market Update: Nasdaq Turns Positive; Global Blood Therapeutics Shares Drop Following Q3 Results
benzinga.com - November 6 at 3:10 PM |
| Global Blood Therapeutics Off on Results Miss, Analyst Rating Cut
finance.yahoo.com - November 6 at 3:10 PM |
| Global Blood Therapeutics, Inc. to Host Earnings Call
marketwatch.com - November 6 at 10:02 AM |
| Global Blood shares tumble 32% after Q3 Oxbryta sales trail estimates; Raymond James cut (GBT) to Market Perform
seekingalpha.com - November 6 at 10:02 AM |
| Global Blood Therapeutics, Inc. (GBT) CEO Ted Love on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 10:59 PM |
| Global Blood Therapeutics (GBT) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 5 at 10:59 PM |
| Global Blood Therapeutics Q3 2020 Earnings Preview
seekingalpha.com - November 4 at 7:42 PM |
| Have Insiders Been Buying Global Blood Therapeutics, Inc. (NASDAQ:GBT) Shares?
finance.yahoo.com - November 2 at 8:58 AM |
| GBT to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020
finance.yahoo.com - October 29 at 1:35 PM |
 | Global Blood Therapeutics, Inc.: GBT Presents Data at 15th Annual Scientific Conference on Sickle Cell and Thalassemia
finanznachrichten.de - October 27 at 5:01 PM |
| GBT Receives Rare Impact Award for Innovation from the National Organization of Rare Disorders (NORD) for Development of Oxbryta® (voxelotor) Tablets
finance.yahoo.com - October 22 at 2:53 PM |
| Report [2020-2026] Sickle Cell Disease Treatment Market Size, Share, Growth, Trends, Analysis, Competitive Landscape, Forecast by Fortune Business Insights™
feeds.benzinga.com - October 13 at 7:15 AM |
| Global Blood Therapeutics, Inc. (0IVZ.L)
au.finance.yahoo.com - October 7 at 6:34 PM |
| Announcing: Global Blood Therapeutics (NASDAQ:GBT) Stock Increased An Energizing 102% In The Last Three Years
finance.yahoo.com - September 17 at 12:23 PM |
| Hedge Funds Have Never Been This Bullish On Global Blood Therapeutics Inc (GBT)
finance.yahoo.com - September 15 at 3:21 AM |
| GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta(R) (voxelotor) in Six Middle Eastern Countries
marketwatch.com - September 9 at 5:17 AM |
| Global Blood Therapeutics inks distribution pact with Biopharma-MEA for SCD med
seekingalpha.com - September 8 at 6:44 PM |
| GBT and Biopharma-MEA Enter Agreement to Distribute Oxbryta® (voxelotor) in Six Middle Eastern Countries
finance.yahoo.com - September 8 at 6:44 PM |
| Why Is Global Blood (GBT) Down 5.6% Since Last Earnings Report?
finance.yahoo.com - September 4 at 1:31 PM |
